Ellagic acid induces cell cycle arrest at G0–G1 in human breast cancer MCF-7 cells mediated by a cyclin A2 and cyclin E2 downregulation and an upregulation of the CDK-inhibitors p21Cip1, p15 and p19 [120]. The gene discussed is CDKN1A; the disease is breast carcinoma.